Literature DB >> 22442109

Autophagy, stress, and cancer metabolism: what doesn't kill you makes you stronger.

R Mathew1, E White.   

Abstract

Altered metabolism is a hallmark of cancer. Oncogenic events that lead to cancerous states reorganize metabolic pathways to increase nutrient uptake, which promotes biosynthetic capabilities and cell-autonomous behavior. Increased biosynthesis dictates metabolic demand for ATP, building blocks, and reducing equivalents, rendering cancer cells metabolically in a perpetually hungry state. Moreover, most chemotherapy agents induce acute metabolic stress that cancer cells must overcome for their survival. These metabolic stress cues in cancer cells can activate and cause dependence on the self-cannibalization mechanism of macroautophagy (autophagy hereafter) for the lysosomal turnover and recycling of organelles and proteins for energy and stress survival. For example, activating mutations in Ras or Ras-effector pathways induce autophagy, and cancer cell lines with Ras activation show elevated levels of basal autophagy that is essential for starvation survival and tumor growth. The metabolic implications of this are profound and multifaceted. First, autophagy-mediated degradation and recycling of cellular substrates can support metabolism and promote survival and tumor growth. Second, acute autophagy activation in response to cancer therapy can potentially lead to refractory tumors resistant to conventional chemotherapy. For example, a specific form of autophagy that targets mitochondria (mitophagy) may also function to promote cell survival by the clearance of damaged mitochondria that are potential sources of reactive oxygen species (ROS). These point to the possibility that autophagy is a unique metabolic need, important for survival as well as therapy resistance in cancer cells. Targeting autophagy in single-agent therapy to sensitize aggressive cancers that are dependent on autophagy for survival or in combination with therapeutic agents that induce autophagy as a resistance mechanism may be an effective therapeutic strategy to treat cancer.

Entities:  

Mesh:

Year:  2012        PMID: 22442109     DOI: 10.1101/sqb.2012.76.011015

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  53 in total

Review 1.  Cellular mechanisms and physiological consequences of redox-dependent signalling.

Authors:  Kira M Holmström; Toren Finkel
Journal:  Nat Rev Mol Cell Biol       Date:  2014-06       Impact factor: 94.444

2.  Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma.

Authors:  Brian A Boone; Nathan Bahary; Amer H Zureikat; A James Moser; Daniel P Normolle; Wen-Chi Wu; Aatur D Singhi; Phillip Bao; David L Bartlett; Lance A Liotta; Virginia Espina; Patricia Loughran; Michael T Lotze; Herbert J Zeh
Journal:  Ann Surg Oncol       Date:  2015-04-24       Impact factor: 5.344

Review 3.  Autophagy at the crossroads of catabolism and anabolism.

Authors:  Jasvinder Kaur; Jayanta Debnath
Journal:  Nat Rev Mol Cell Biol       Date:  2015-07-15       Impact factor: 94.444

Review 4.  Autophagy modulation as a target for anticancer drug discovery.

Authors:  Xin Li; Huai-long Xu; Yong-xi Liu; Na An; Si Zhao; Jin-ku Bao
Journal:  Acta Pharmacol Sin       Date:  2013-04-08       Impact factor: 6.150

Review 5.  MUC1: a novel metabolic master regulator.

Authors:  Kamiya Mehla; Pankaj K Singh
Journal:  Biochim Biophys Acta       Date:  2014-01-11

6.  Aberrant SIRT6 expression contributes to melanoma growth: Role of the autophagy paradox and IGF-AKT signaling.

Authors:  Liwen Wang; Weinan Guo; Jinyuan Ma; Wei Dai; Lin Liu; Sen Guo; Jiaxi Chen; Huina Wang; Yuqi Yang; Xiuli Yi; Gang Wang; Tianwen Gao; Guannan Zhu; Chunying Li
Journal:  Autophagy       Date:  2017-12-31       Impact factor: 16.016

Review 7.  Rapamycin-resistant effector T-cell therapy.

Authors:  Daniel H Fowler
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

8.  Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux.

Authors:  Buddhini Samarasinghe; Christina T K Wales; Frederick R Taylor; Aaron T Jacobs
Journal:  Biochem Pharmacol       Date:  2013-11-28       Impact factor: 5.858

Review 9.  Autophagy: a targetable linchpin of cancer cell metabolism.

Authors:  Robert D Leone; Ravi K Amaravadi
Journal:  Trends Endocrinol Metab       Date:  2013-03-06       Impact factor: 12.015

10.  Autophagy in oncogenic K-Ras promotes basal extrusion of epithelial cells by degrading S1P.

Authors:  Gloria Slattum; Yapeng Gu; Roger Sabbadini; Jody Rosenblatt
Journal:  Curr Biol       Date:  2013-12-19       Impact factor: 10.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.